(Q45747606)

15 December 2017

title

Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus (English)

1 reference

15 December 2017

1 reference

1 reference

1 reference

7

Purcell RH

1 reference

15 December 2017

John L. Gerin

6

object named as

Gerin J

1 reference

15 December 2017

Paul J. Cote

2

object named as

Cote PJ

1 reference

15 December 2017

author name string

Ogata N

1

1 reference

15 December 2017

Zanetti AR

3

1 reference

15 December 2017

Miller RH

4

1 reference

15 December 2017

Shapiro M

5

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

15 December 2017

published in

Hepatology

1 reference

15 December 2017

volume

30

1 reference

15 December 2017

issue

3

1 reference

15 December 2017

page(s)

779-786

1 reference

15 December 2017

Molecular characterization of envelope antigenic variants of hepatitis B virus from Spain

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

Hepatitis B variant in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Vaccine-induced escape mutant of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Independent emergence of a vaccine-induced escape mutant of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Gly145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Mutations in S region of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Molecular epidemiology of hepatitis B virus vaccine variants in Singapore

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Breakthrough infections and identification of a viral variant in Gambian children immunized with hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

A novel hepatitis B virus variant in the sera of immunized children

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Glycine-to-arginine substitution at codon 145 of HBsAg in two infants born to hepatitis B e antigen-positive carrier

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

A new immune escape mutant of hepatitis B virus with an Asp to Ala substitution in aa144 of the envelope major protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Detection of Hepatitis B Surface Gene Mutation in Carrier Children with or without Immunoprophylaxis at Birth

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Low detection rate and maternal provenance of hepatitis B virus S gene mutants in cases of failed postnatal immunoprophylaxis in England and Wales

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Altered antigenicity of 'a' determinant variants of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Efficacy of immunization of high-risk infants against hepatitis B virus evaluated by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Molecular epidemiology and variation of hepatitis B in recent immigrant families to Australia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Emergence of hepatitis B virus S gene mutant in a liver transplant recipient.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Hepatitis B virus surface mutations associated with infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Evidence for selection of hepatitis B mutants after liver transplantation through peripheral blood mononuclear cell infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Increasing heterogeneity of the 'a' determinant of HBsAg found in the presumed late phase of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Infectivity and pathogenicity in chimpanzees of a surface gene mutant of hepatitis B virus that emerged in a vaccinated infant

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Human hepatitis B vaccine from recombinant yeast

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Production and immunological analysis of recombinant hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Development and production aspects of a recombinant yeast-derived hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the a determinant of hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

The complete nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Safety and immunogenicity of a purified hepatitis B virus vaccine prepared by using recombinant DNA technology

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Use of and interpretation of results using inocula of hepatitis B virus with known infectivity titers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Hepatitis B e antigen and infectivity of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

The structure of hepatitis B envelope and molecular variants of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

In vivo selection of a hepatitis B virus mutant with abnormal viral protein expression

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Successful postexposure vaccination against hepatitis B in chimpanzees

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Hepatitis B vaccine in the prevention of perinatally transmitted hepatitis B virus infection: final report on a West Midlands pilot study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Long-term efficacy of active postexposure immunization of infants for prevention of hepatitis B virus infection. United States-People's Republic of China Study Group on Hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Prevention of maternal-infant hepatitis B virus transmission by immunization: the role of serum hepatitis B virus DNA.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Demonstration of mother-to-infant transmission of hepatitis B virus by means of polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Selective unresponsiveness to HBsAg vaccine in newborns related with an in utero passage of hepatitis B virus DNA.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

The immune response to hepatitis B vaccine in humans: inheritance patterns in families

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Ethnic differences in immune responses to hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Hepatitis B virus immunopathogenesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Variant of hepatitis B virus isolated in Zimbabwe

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Discontinuous epitopes of hepatitis B surface antigen derived from a filamentous phage peptide library

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Specificity of antibodies reactive with hepatitis B surface antigen following immunization with synthetic peptides

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Hepatitis B surface antigen variation and protective immunity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Current aspects of hepatitis B surface antigen mutants in Singapore

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Current status of HBV vaccine escape variants--a mathematical model of their epidemiology

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300309

7 January 2021

Identifiers

DOI

10.1002/HEP.510300309

1 reference

15 December 2017

PubMed ID

10462386

1 reference

15 December 2017